Ardelyx (ARDX)
(Delayed Data from NSDQ)
$9.31 USD
+0.16 (1.75%)
Updated May 7, 2024 04:00 PM ET
After-Market: $9.29 -0.02 (-0.21%) 5:48 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Income Statements
Fiscal Year end for Ardelyx, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 124 | 52 | 10 | 8 | 5 |
Cost Of Goods | 18 | 4 | 1 | 0 | 1 |
Gross Profit | 107 | 48 | 9 | 7 | 5 |
Selling & Adminstrative & Depr. & Amort Expenses | 170 | 112 | 163 | 98 | 96 |
Income After Depreciation & Amortization | -63 | -64 | -154 | -91 | -91 |
Non-Operating Income | 7 | 2 | 1 | 2 | 2 |
Interest Expense | 9 | 5 | 5 | 5 | 6 |
Pretax Income | -66 | -67 | -158 | -94 | -95 |
Income Taxes | 1 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -66 | -67 | -158 | -94 | -95 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -66 | -67 | -158 | -94 | -95 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -62 | -63 | -152 | -88 | -88 |
Depreciation & Amortization (Cash Flow) | 1 | 1 | 3 | 3 | 3 |
Income After Depreciation & Amortization | -63 | -64 | -154 | -91 | -91 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 219.33 | 158.69 | 104.21 | 89.58 | 64.48 |
Diluted EPS Before Non-Recurring Items | -0.30 | -0.42 | -1.52 | -1.05 | -1.47 |
Diluted Net EPS (GAAP) | -0.30 | -0.42 | -1.52 | -1.05 | -1.47 |
Fiscal Year end for Ardelyx, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | 46.02 | 34.36 | 56.39 | 22.33 | 11.37 |
Cost Of Goods | 7.13 | 5.08 | 7.69 | 3.49 | 1.54 |
Gross Profit | 38.90 | 29.29 | 48.70 | 18.84 | 9.83 |
SG&A, R&D, and Dept/Amort Expenses | 63.57 | 57.27 | 41.30 | 35.47 | 35.89 |
Income After SG&A, R&D, and Dept/Amort Expenses | -24.67 | -27.98 | 7.40 | -16.63 | -26.06 |
Non-Operating Income | 2.34 | 2.32 | 1.46 | 1.55 | 1.30 |
Interest Expense | 4.06 | 2.80 | 2.03 | 2.04 | 2.00 |
Pretax Income | -26.40 | -28.47 | 6.83 | -17.12 | -26.76 |
Income Taxes | 0.12 | 0.33 | 0.20 | 0.00 | 0.01 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -26.52 | -28.80 | 6.63 | -17.12 | -26.77 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -26.52 | -28.80 | 6.63 | -17.12 | -26.77 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | 233.07 | 232.25 | 227.89 | 214.95 | 207.02 |
Diluted EPS Before Non-Recurring Items | -0.11 | -0.12 | 0.03 | -0.08 | -0.13 |
Diluted Net EPS (GAAP) | -0.11 | -0.12 | 0.03 | -0.08 | -0.13 |